Am

Amyloid

Amyloid: The Journal of Protein Folding Disorders is the official journal of the International Society of Amyloidosis and publishes basic and clinical research on amyloids and systemic and localized amyloidosis. Its scope includes etiology, epidemiology, genetics, pathogenesis, pathology, diagnosis, treatment, and prognosis across clinical specialties affected by amyloid diseases and related disorders. The journal publishes research articles, letters to the Editor, review articles, and article commentaries, with commentaries typically by invitation.

Looking to publish in Amyloid? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Medicine, General & Internal, Medicine, Research & Experimental
Impact Factor 7.4
Quartile Q1
Open Access Type Closed
ISSN 1350-6129
eISSN 1744-2818
Invitation Only No
Cost Range Institutional subscription: USD 3,043.00 online only or USD 4,449.00 print and online; personal subscription pricing available on request.

Submission Instructions

Amyloid accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. The abstract must be 200 words. The abstract must be structured. The abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript The manuscript must be no more than 4000 words excluding tables, references, and figure or table captions. The manuscript must be ordered as Title, Authors with affiliations, Abbreviations, Structured abstract, Introduction, Material and methods, Results, Discussion, Acknowledgments, Disclosure statement, and Funding. The manuscript must include 5 to 7 keywords and must acknowledge any use of AI in the paper.
References References must use the T&F standard NLM reference style.
Figures & Tables The manuscript must include no more than 6 figures and tables combined. Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. The abstract must be structured.
Manuscript The manuscript must be ordered as Title, Authors with affiliations, Abbreviations, Structured abstract, Body Text with appropriate headings of the author's choosing, Acknowledgments, Disclosure statement, and Funding. The manuscript must include 5 to 7 keywords and must acknowledge any use of AI in the paper.
References References must use the T&F standard NLM reference style.
Figures & Tables Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must be no more than 1200 words, excluding tables, references, and figure or table captions. Letters to the Editor must be ordered as Title, Authors with affiliations, Text without headings, Acknowledgments, Disclosure statement, Funding, and Supplementary Material, and must begin with the text 'To the Editors.' Letters to the Editor must include 5 to 7 keywords.
References Letters to the Editor must include no more than 10 references. References must use the T&F standard NLM reference style.
Figures & Tables Letters to the Editor must include no more than 1 figure or table. Figures should be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Article Commentary

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Article Commentary must not exceed 1200 words including tables, references, figure or table captions, and footnotes. Article Commentary text may be divided into subsections with short, informative headings, and the Amyloid article being commented on must be cited in the first sentence. Article Commentary must include 5 to 7 keywords, a disclosure statement, funding details, and acknowledgement of any AI tool use.
References Article Commentary must include no more than 10 references. References must use the T&F standard NLM reference style. The Amyloid article being commented on must appear as the first reference in the reference list.
Figures & Tables Article Commentary must include no more than 1 figure. Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Recent Publications

Assessing hemorrhagic risk in transthyretin cardiac amyloidosis. The haemorrhagic–embolic conundrum

Silvia Vilches

10.1080/13506129.2026.2683425
View Publication

Transient focal neurological episodes in hereditary transthyretin-related amyloidosis treated with liver transplantation: electroencephalographic insights and clinical features

Gonçalo Videira, João Moura, Joel Freitas, Cristina Alves, Márcio Neves Cardoso, Ana Paula Sousa, Miguel Mendonça Pinto, Diogo Pereira, Luísa Sousa, Sara Cavaco, Teresa Coelho

10.1080/13506129.2026.2676845
View Publication

RNA-based full length immunoglobulin light chain sequencing reveals lambda constant domain mutations with potential implications for thermodynamic stability in light chain amyloidosis

Eyad Naser, Sara Oubari, Josefine Jakob, Björn Häupl, Bettina Budeus, Bernd Walkenfort, Melanie Nowakowski, Gabriele Hessler, Claudine Kühn, Mike Hasenberg, Thomas Oellerich, Hans Christian Reinhardt, Alexander Carpinteiro

10.1080/13506129.2026.2679153
View Publication

Efficacy of diflunisal for hereditary transthyretin amyloidosis: the Swedish real-world experience

John L. Berk, Kevin J. Carroll, Jorge Mejia Baranda, Björn Pilebro, Kristin Samuelsson, Per Eldhagen, Jonas Wixner

10.1080/13506129.2026.2678340
View Publication

Correction

-

10.1080/13506129.2026.2680374
View Publication

Frequently asked questions

How long does it take to publish?

11 days average from submission to first decision; 29 days average from submission to first post-review decision; 12 days average from acceptance to online publication.

Reformat to Amyloid using Livewrite Premium

What are the publication costs?

Institutional subscription: USD 3,043.00 online only or USD 4,449.00 print and online; personal subscription pricing available on request.

Reformat to Amyloid using Livewrite Premium

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes Alzheimer's disease research and treatments Parathyroid Disorders and Treatments Dermatological and Skeletal Disorders Protein Kinase Regulation and GTPase Signaling Cellular transport and secretion Drug Transport and Resistance Mechanisms Trace Elements in Health Multiple Myeloma Research and Treatments Prion Diseases and Protein Misfolding Peptidase Inhibition and Analysis Coagulation, Bradykinin, Polyphosphates, and Angioedema Skin and Cellular Biology Research Pancreatitis Pathology and Treatment Neuroendocrine Tumor Research Advances Medical Imaging and Pathology Studies IgG4-Related and Inflammatory Diseases Protein Structure and Dynamics Eosinophilic Disorders and Syndromes Sarcoidosis and Beryllium Toxicity Research Cardiovascular Function and Risk Factors Ion channel regulation and function Pneumocystis jirovecii pneumonia detection and treatment Intracerebral and Subarachnoid Hemorrhage Research Caveolin-1 and cellular processes

Related Journals

MC
Mayo Clinic Proceedings Elsevier BV
DÄ
Deutsches Ärzteblatt international Deutscher Ärzte-Verlag
AI
Advances in Therapy Adis, Springer Healthcare
CB
Cancer Biology and Medicine Chinese Anti-Cancer Association
GT
Gene Therapy Springer Nature
EO
Expert Opinion on Drug Delivery Taylor & Francis